ATF4 inhibitors (Columbia University/Columbia University Technology Ventures)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameATF4 inhibitors (Columbia University/Columbia University Technology Ventures)
Drug Alias Nameactivating transcription factor 4 inhibitors (Columbia University/Columbia University Technology Ventures)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclic AMP-dependent transcription factor ATF-4 inhibitors
TargetsCyclic AMP-dependent transcription factor ATF-4
Therapy Area/IndicationsAlzheimer DiseaseNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColumbia Technology VenturesColumbia University
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A